Editors’ Picks, April 2024: Targeting Metabolism, KRAS, and More
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
Progress Against Cancer
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
February’s selections include a modified Zika virus to treat cancer, insights into treatment resistance, and more.
January’s selections include disparities in genetic testing, updates from a breast cancer clinical trial, and more.
Highlights of December 2023 AACR journals include clinical trial results, strategies to improve therapy, and a new cervical cancer...
As you prepare for trick-or-treating, check out the articles selected by the editors of the 10 AACR journals for...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...